pricing Archives -

Latin America: How pharma can navigate a complex market

https://pharmaphorum.com/views-analysis-market-access/latin-america-how-pharma-can-navigate-a-complex-market/

FDA approves Alnylam’s ultra-rare disease drug Oxlumo

https://pharmaphorum.com/news/fda-approves-alynlams-ultra-rare-disease-drug-oxlumo/

Analysis casts doubt on increased use of telehealth after pandemic

https://pharmaphorum.com/news/analysis-casts-doubt-on-increased-use-of-telehealth-after-pandemic/

Roche takes on pricey rivals as FDA approves SMA drug

https://pharmaphorum.com/news/roche-takes-on-pricey-rivals-as-fda-approves-sma-drug/

Windrose Consulting Group acquires Parioforma

https://pharmaphorum.com/partner-content/windrose-consulting-group-acquires-parioforma/

Survey shows patients wait six times longer than EU neighbours for new drugs

https://pharmaphorum.com/news/survey-shows-patients-wait-six-times-longer-than-eu-neighbours-for-new-drugs/

The unprecedented challenge of pricing a coronavirus vaccine

https://pharmaphorum.com/views-analysis-market-access/the-unprecedented-challenge-of-pricing-a-coronavirus-vaccine/

Gilead’s remdesivir could be $7.7bn blockbuster – analyst

https://pharmaphorum.com/news/gileads-remdesivir-could-be-7-7bn-blockbuster-analyst/

‘Delusional’ Shkreli refused prison release to fight coronavirus

https://pharmaphorum.com/news/delusional-shkreli-refused-prison-release-to-fight-coronavirus/

Search